The Prevalence, Clinical Determinants, and Long-Term Prognostic Impact

Konrad Stępień,Karol Nowak,Aleksandra Karcińska,Grzegorz Horosin,Alicia del Carmen Yika,Julia Lenart,Anna Górowska,Sylwia Iwańczyk,Mateusz Podolec,Aleksander Siniarski,Jadwiga Nessler,Jarosław Zalewski
DOI: https://doi.org/10.3390/ijms25021297
IF: 5.6
2024-01-20
International Journal of Molecular Sciences
Abstract:Patients with takotsubo syndrome (TTS) may present coronary slow flow (CSF) in angiography performed in the acute myocardial infarction (MI). However, the detailed clinical relevance and its long-term impact remain poorly understood. Among 7771 MI patients hospitalized between 2012 and 2019, TTS was identified in 82 (1.1%) subjects. The epicardial blood flow was assessed with thrombolysis in myocardial infarction (TIMI) scale and corrected TIMI frame count (TFC), whereas myocardial perfusion with TIMI myocardial perfusion grade (TMPG). CSF was defined as TIMI-2 or corrected TFC > 27 frames in at least one epicardial vessel. CSF was identified in 33 (40.2%) TTS patients. In the CSF-TTS versus normal-flow-TTS group, lower values of left ventricular ejection fraction on admission (33.5 (25–40) vs. 40 (35–45)%, p = 0.019), more frequent midventricular TTS (27.3 vs. 8.2%, p = 0.020) and the coexistence of both physical and emotional triggers (9.1 vs. 0%, p = 0.032) were noted. Within a median observation of 55 months, higher all-cause mortality was found in CSF-TTS compared with normal-flow TTS (30.3 vs. 10.2%, p = 0.024). CSF was identified as an independent predictor of long-term mortality (hazard ratio 10.09, 95% confidence interval 2.12–48.00, p = 0.004). CSF identified in two-fifths of TTS patients was associated with unfavorable long-term outcomes.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?